We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Data from Historic Phase IIb Clinical Trial for Tuberculosis Vaccine Candidate Published

News   Feb 04, 2013

 
Data from Historic Phase IIb Clinical Trial for Tuberculosis Vaccine Candidate Published
 
 
 

RELATED ARTICLES

Scientists Produce a Potential Vitamin and Alzheimer’s Drug in Yeast

News

By engineering and optimizing baker's yeast, scientists from The Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) has for the first time exploited the potential of making ergothioneine in yeast in a bio-based fashion.

READ MORE

Anti-inflammatory Drug May Raise Diabetes Risk

News

A commonly prescribed anti-inflammatory drug may increase diabetes risk after just one week of treatment, according to new findings presented at The Society for Endocrinology Annual Conference.

READ MORE

The Gut Could Be Key To Cutting Chemo’s Side Effects

News

Scientists have observed several simultaneous reactions in mice given a chemotherapy drug... their gut bacteria and tissue changed, their blood and brains showed signs of inflammation, and their behaviors suggested they were fatigued and cognitively impaired.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE